Colombian Engineers’ Ventilators to Be Tested in COVID Patients

In just a few months, researchers have constructed low-cost ventilators that can keep sedated pigs alive. Getting them to work safely and reliably in people is the next challenge.

Written byKatarina Zimmer
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

ABOVE: Engineers at University of La Sabana have put their prototype ventilator, which costs less than $3,000 to build, through a series of tests.
COURTESY OF UNIVERSITY OF LA SABANA

In March, as Colombia’s coronavirus cases were taking off, officials there selected a number of hospitals in the country to look after COVID-19 patients in need of intensive care. The University of La Sabana Teaching Hospital in the small city of Chía just outside Bogotá was to take in patients from across the Cundinamarca region, a patch of Andean plateau with nearly 3 million inhabitants. But the hospital only had 25 ventilators—hardly enough for the hundreds of patients expected to become so sick they’d need mechanical aid to breathe.

With no affordable ventilator options on the market, the vice president of University of La Sabana turned to Julian Echeverry and his colleagues in the institution’s mechanical engineering department, asking if ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies